UFP Technologies Inc
NASDAQ:UFPT
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
155.66
358.42
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
UFP Technologies Inc
UFP Technologies Inc
Cash & Cash Equivalents
UFP Technologies Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
UFP Technologies Inc
NASDAQ:UFPT
|
Cash & Cash Equivalents
$16.4m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-7%
|
|
|
Haemonetics Corp
NYSE:HAE
|
Cash & Cash Equivalents
$299.3m
|
CAGR 3-Years
16%
|
CAGR 5-Years
22%
|
CAGR 10-Years
9%
|
|
|
ICU Medical Inc
NASDAQ:ICUI
|
Cash & Cash Equivalents
$312.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
0%
|
CAGR 10-Years
2%
|
|
|
Align Technology Inc
NASDAQ:ALGN
|
Cash & Cash Equivalents
$1B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
16%
|
CAGR 10-Years
19%
|
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Cash & Cash Equivalents
$866.4m
|
CAGR 3-Years
112%
|
CAGR 5-Years
62%
|
CAGR 10-Years
41%
|
|
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Cash & Cash Equivalents
$523.1m
|
CAGR 3-Years
97%
|
CAGR 5-Years
70%
|
CAGR 10-Years
55%
|
|
UFP Technologies Inc
Glance View
UFP Technologies, Inc. engages in designing and custom manufacturing of components, subassemblies, products and packaging utilizing specialized foams, films, and plastics primarily for the medical market. The company is headquartered in Newburyport, Massachusetts and currently employs 1,828 full-time employees. The firm's single-use and single-patient devices and components are used in a range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods and orthopedic implant packaging. The firm also provides engineered products and components to customers in the automotive, aerospace and defense, consumer, electronics, and industrial markets. The applications of its products include military uniform and gear components, automotive interior trim, athletic padding, environmentally friendly protective packaging, air filtration, abrasive nail files, and protective cases and inserts. Its wholly owned subsidiaries include Moulded Fibre Technology, Inc., Simco Industries, Inc., Dielectrics, Inc., Contech Medical, Inc. and UFP Realty LLC.
See Also
What is UFP Technologies Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
16.4m
USD
Based on the financial report for Sep 30, 2024, UFP Technologies Inc's Cash & Cash Equivalents amounts to 16.4m USD.
What is UFP Technologies Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
-7%
Over the last year, the Cash & Cash Equivalents growth was 156%. The average annual Cash & Cash Equivalents growth rates for UFP Technologies Inc have been -21% over the past three years , 7% over the past five years , and -7% over the past ten years .
You don't have any saved screeners yet
